Comment: Compulsory Licensing of Patented Pharmaceutical Inventions: Evaluating the Options

  title={Comment: Compulsory Licensing of Patented Pharmaceutical Inventions: Evaluating the Options},
  author={J. Reichman},
  journal={The Journal of Law, Medicine \& Ethics},
  pages={247 - 263}
  • J. Reichman
  • Published 2009
  • Business, Medicine, Economics
  • The Journal of Law, Medicine & Ethics
In this Comment, the author traces the relevant legislative history pertaining to compulsory licensing of patented pharmaceuticals from the TRIPS Agreement of 1994 to the 2003 waiver to, and later proposed amendment of, article 31, which enables poor countries to obtain needed medicines from other countries that possess manufacturing capacity. The Comment then evaluates recent, controversial uses of the relevant legislative machinery as viewed from different critical perspectives. The Comment… Expand
Compulsory Licensing of Patents in India
Compulsory licensing is defined generally as the granting of a license by a government to use a patent without the patent-holder’s permission. As applied to international intellectual propertyExpand
Compulsory licensing and access to drugs
It is shown that both access to drugs and pharmaceutical innovation depend largely on the Southern country’s ability to manufacture a generic version and the overall impact of compulsory licensing can be positive, even when accounting for its impact on innovation. Expand
Property rights, compulsory licensing and public health in developing countries: from an institutional controversy to another one
When the TRIPS agreement was ratified in 1994, concerns were raised about the effect of a significant strengthening of intellectual property rights (IPRs) in the developing world. To date, thisExpand
Current Scenario of Patent Act: Compulsory Licensing
Process of compulsory licensing glared after the Doha declaration. Doha declaration explored the way for compulsory licensing around the globe and also insisted that TRIPS agreement does not andExpand
Antitrust and Compulsory Licensing in BRICS and Developing Countries
Compulsory licensing is a powerful tool for broadening access to inventions protected by intellectual property rights without the rights owner consent, and is highly disciplined by International LawExpand
Evolution of the Concept of Compulsory Licensing: A Critical Analysis of Key Developments Before and After Trips
Patents provide monopoly rights to patent holders. There are safeguards in patent regime to ensure that exclusive right of the patent holder is not misused. Compulsory licensing is one of theExpand
Using TRIPS flexibilities to facilitate access to medicines.
It is argued that high-income nations should refocus on their moral obligation to enact appropriate legislative mechanisms and provide appropriate incentives for their use and draft legislation currently being considered in Australia is used to illustrate how workable legislative frameworks can be developed. Expand
The patentability of medical products : identifying responsibilities of pharmaceutical corporations towards the right to health
Each year, billions of people lack adequate access to urgently required medicines, leading to unnecessary suffering and the loss of millions of lives from preventable conditions. One of the mainExpand
Is the Patent System a Barrier to Inclusive Prosperity? The Biomedical Perspective
textabstractAs patents grant monopolies, the patent system has a considerable impact on markets. When corporations use certain patent strategies, social welfare can be damaged. This article focusesExpand
Patents, trade and medicines: past, present and future
Abstract This article analyzes the spread of intellectual property in trade agreements. We explain how the integration of intellectual property with international trade rules led to the globalizationExpand


Rethinking Trips: ‘Adequate Remuneration’ for Non-Voluntary Patent Licensing
Driven by concerns about access to medicines, the World Trade Organization (WTO) Doha Declaration on the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement and Public Health andExpand
Canada – Patent Protection of Pharmaceutical Products
This concise and detailed Handbook addresses some of the most complex issues raised by the implementation of the TRIPS Agreement globally. Among other themes, the Handbook explores the applicabilityExpand
Trips, Pharmaceuticals, Developing Countries, and the Doha 'Solution'
  • A. Sykes
  • Business, Medicine
  • Chicago journal of international law
  • 2002
The WTO ministerial meeting in Doha produced a declaration that will encourage developing nations to use compulsory licensing and parallel importation to reduce the prices of patented pharmaceuticalsExpand
An Economic Justification for Open Access to Essential Medicine Patents in Developing Countries
Open licenses that permit any qualified firm to supply the market on the same terms, such as may be available under licenses of right or essential facility legal standards, can be used to mitigate the negative effects of government-granted patents, thereby increasing overall social welfare. Expand
Pharmaceutical Arbitrage: Balancing Access and Innovation in International Prescription Drug Markets
  • K. Outterson
  • Economics, Medicine
  • Yale journal of health policy, law, and ethics
  • 2005
The heuristic of globally optimal appropriation alters some of the received wisdom on pharmaceutical pricing, suggesting that nonrival access to prescription drugs can be provided to low and middle income populations for all global diseases without harming innovation. Expand
Compulsory Licensing in Canada and Thailand: Comparing Regimes to Ensure Legitimate Use of the WTO Rules
  • K. Lybecker, Elisabeth Fowler
  • Medicine, Political Science
  • The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics
  • 2009
A rubric is constructed to evaluate characteristics of a successful regime and guide changes to compulsory licensing design to ensure that legitimate regimes are embraced while illegitimate ones are disallowed. Expand
Using Liability Rules to Stimulate Local Innovation in Developing Countries: Application to Traditional Knowledge
When economists speak of an underlying legal structure that imposes an “absolute permission” requirement on access to, and use of, knowledge goods protected by intellectual property rights (IPRs),Expand
The Doha Round's Public Health Legacy: Strategies for the Production and Diffusion of Patented Medicines Under the Amended TRIPS Provisions
The entry into force of the World Trade Organization (WTO) TRIPS Agreement in 1995 transformed the international intellectual property system. The harmonization of basic intellectual propertyExpand
A Note on Global Welfare in Pharmaceutical Patenting
This paper revisits the question of whether global welfare is higher under a uniform world-wide system of pharmaceutical product patents or with international rules allowing low-income nations toExpand
Disease-Based Limitations on Compulsory Licenses Under Articles 31 and 31bis
Compulsory licensure is one of the flexibilities retained under TRIPS to permit countries to support public health while granting pharmaceutical patents. The United States Government appears to takeExpand